Adicet Bio, Inc.
ACET· Nasdaq
Released Aug 7, 2025, after the close
10-Q filed Aug 7, 2025, 38 days after period end · 0000950170-25-104978
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$31.22M | -$29.90M | -$32.40M | -$22.54M |
| EPS Diluted | -$5.48 | -$0.33 | -$0.75 | -$0.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR